CLINICAL_TRIALS trial_result · 2017-06-14

Clinical Trial Update: Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) [Phase 3]

Phase 3 trial assessing safety and efficacy of SHP465 in adults with ADHD completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Shire | Conditions: Attention Deficit Hyperactivity Disorder (ADHD) | Phase 3 | Status: COMPLETED | Results posted: 2017-06-14